The Top Line

Available every Friday morning, The Top Line podcast will recap the biggest news and why it matters—from mergers and marketing to drug R&D and device development.

Graphic for The Top Line podcast featuring a pale blue background with a repeating pattern of blue-and-white capsules a
Podcast

The deal before the deal

Big Pharma dealmaking has picked up, but the biotech path to a signed agreement is still anything but simple.
Ayla Ellison , James Waldron Jun 26, 2026 9:20am
A blue-toned graphic showing assorted pills and capsules scattered across a close-up of a 100 bill with Benjamin Franklin

Ipsen R&D chief on pipeline discipline and 2026 milestones

Jun 12, 2026 9:57am
Chemical formula pattern and DNA background

Boston, China and the future of biotech

May 29, 2026 9:09am
Top drug launches of 2026

BioAge CEO talks NLRP3 and ‘pipeline in a pill’ ambitions

May 22, 2026 10:00am
Blue background with pill pattern with the words The Top Line

Roivant’s CEO thinks China is a ‘red herring’

Apr 17, 2026 8:35am
Behind the curtain What Xaira is building after its 1B fundraise

What Xaira is building after its $1B fundraise

Mar 20, 2026 10:34am